Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
28550260
PubMed Central
PMC5523910
DOI
10.3233/jad-170102
PII: JAD170102
Knihovny.cz E-zdroje
- Klíčová slova
- Alzheimer’s disease, dementia, diagnostics, solitary living, treatment,
- MeSH
- Alzheimerova nemoc farmakoterapie epidemiologie psychologie MeSH
- antidepresiva MeSH
- antipsychotika terapeutické užití MeSH
- demence epidemiologie psychologie MeSH
- kohortové studie MeSH
- komorbidita MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- registrace * MeSH
- samostatný způsob života MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- sociální podmínky * MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Švédsko epidemiologie MeSH
- Názvy látek
- antidepresiva MeSH
- antipsychotika MeSH
BACKGROUND: Many people with Alzheimer's disease (AD) live alone in their own homes. There is a lack of knowledge about whether these individuals receive the same quality of diagnostics and treatment for AD as patients who are cohabiting. OBJECTIVES: To investigate the diagnostic work-up and treatment of community-dwelling AD patients who live alone. METHODS: We performed a cross-sectional cohort study based on data from the Swedish Dementia Registry (SveDem). We studied patients diagnosed with AD between 2007 and 2015 (n = 26,163). Information about drugs and comorbidities was acquired from the Swedish Prescribed Drug Register and the Swedish Patient Register. RESULTS: 11,878 (46%) patients lived alone, primarily older women. After adjusting for confounders, living alone was inversely associated with receiving computed tomography (OR 0.90; 95% CI 0.82-0.99), magnetic resonance imaging (OR 0.91; 95% CI 0.83-0.99), and lumbar puncture (OR 0.86; 95% CI 0.80-0.92). Living alone was also negatively associated with the use of cholinesterase inhibitors (OR 0.81; 95% CI 0.76; 0.87), memantine (OR 0.77; 95% CI 0.72; 0.83), and cardiovascular medication (OR 0.92; 0.86; 0.99). On the other hand, living alone was positively associated with the use of antidepressants (OR 1.15; 95% CI 1.08; 1.22), antipsychotics (OR 1.41; 95% CI 1.25; 1.58), and hypnotics and sedatives (OR 1.09; 95% CI 1.02; 1.17). CONCLUSIONS: Solitary living AD patients do not receive the same extent of care as those who are cohabiting.
Aging Research Center Karolinska Institutet and Stockholm University Stockholm Sweden
Department of Geriatric Medicine Karolinska University Hospital Stockholm Sweden
Department of Public Health Geriatrics Uppsala University Uppsala Sweden
National Instituteof Mental Health Klecany Czech Republic
Södersjukhuset Department of Internal Medicine Neurology Stockholm Sweden
Zobrazit více v PubMed
Tomassini C, Glaser K, Wolf DA, Broese van Groenou MI, Grundy E (2004) Living arrangements among older people: An overview of trends in Europe and the USA. Popul Trends 24–34. PubMed
Wattmo C, Londos E, Minthon L (2014) Solitary living in Alzheimer’s disease over 3 years: Association between cognitive and functional impairment and community-based services. Clin Interv Aging 9, 1951–1962. PubMed PMC
Pimouguet C, Rizzuto D, Schon P, Shakersain B, Angleman S, Lagergren M, Fratiglioni L, Xu W (2016) Impact of living alone on institutionalization and mortality: A population-based longitudinal study. Eur J Public Health 26, 182–187. PubMed
Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: A community-based longitudinal study. Lancet 355, 1315–1319. PubMed
Hakansson K, Rovio S, Helkala EL, Vilska AR, Winblad B, Soininen H, Nissinen A, Mohammed AH, Kivipelto M (2009) Association between mid-life marital status and cognitive function in later life: Population based cohort study. BMJ 339, b2462. PubMed PMC
Walker D, Beauchene RE (1991) The relationship of loneliness, social isolation, and physical health to dietary adequacy of independently living elderly. J Am Diet Assoc 91, 300–304. PubMed
Stahl ST, Beach SR, Musa D, Schulz R (2016) Living alone and depression: The modifying role of the perceived neighborhood environment. Aging Ment Health, 1–7. doi: 10.1080/13607863.2016.1191060 [Epub ahead of print]. PubMed DOI PMC
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jonsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H (2016) Defeating Alzheimer’s disease and other dementias: A priority for European science and society. Lancet Neurol 15, 455–532. PubMed
Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Update on hypothetical model of Alzheimer’s disease biomarkers. Lancet Neurol 12, 207–216. PubMed PMC
Webber PA, Fox P, Burnette D (1994) Living alone with Alzheimer’s disease: Effects on health and social service utilization patterns. Gerontologist 34, 8–14. PubMed
Soto M, Andrieu S, Gares V, Cesari M, Gillette-Guyonnet S, Cantet C, Vellas B, Nourhashemi F (2015) Living alone with Alzheimer’s disease and the risk of adverse outcomes: Results from the Plan de Soin et d’Aide dans la maladie d’Alzheimer Study. J Am Geriatr Soc 63, 651–658. PubMed
Nourhashemi F, Amouyal-Barkate K, Gillette-Guyonnet S, Cantet C, Vellas B, Group RF (2005) Living alone with Alzheimer’s disease: Cross-sectional and longitudinal analysis in the REAL.FR Study. J Nutr Health Aging 9, 117–120. PubMed
Mets T, De Deyn PP, Pals P, De Lepeleire J, Vandewoude M, Ventura M, Ivanoiu A, Albert A, Seghers AK, COGNOS group (2013) COGNOS: Care for people with cognitive dysfunction: A national observational study. Alzheimer Dis Assoc Disord 27, 123–132. PubMed
Hansen ML, Waldorff FB, Waldemar G (2011) Prognostic factors for weight loss over 1-year period in patients recently diagnosed with mild Alzheimer disease. Alzheimer Dis Assoc Disord 25, 269–275. PubMed
Religa D, Fereshtehnejad SM, Cermakova P, Edlund AK, Garcia-Ptacek S, Granqvist N, Hallback A, Kawe K, Farahmand B, Kilander L, Mattsson UB, Nagga K, Nordstrom P, Wijk H, Wimo A, Winblad B, Eriksdotter M (2015) SveDem, the Swedish Dementia Registry - atool for improving the quality of diagnostics, treatment and careof dementia patients in clinical practice. PLoS One 10, e0116538. PubMed PMC
Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M (2007) The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16, 726–735. PubMed
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11, 450. PubMed PMC
Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154, 854–864. PubMed
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40, 373–383. PubMed
Cermakova P, Fereshtehnejad SM, Johnell K, Winblad B, Eriksdotter M, Religa D (2014) Cardiovascular medication burden in dementia disorders: A nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. Alzheimers Res Ther 6, 34. PubMed PMC
Cermakova P, Lund LH, Fereshtehnejad SM, Johnell K, Winblad B, Dahlstrom U, Eriksdotter M, Religa D (2015) Heart failure and dementia: Survival in relation to types of heart failure and different dementia disorders. Eur J Heart Fail 17, 612–619. PubMed PMC
Cermakova P, Johnell K, Fastbom J, Garcia-Ptacek S, Lund LH, Winblad B, Eriksdotter M, Religa D (2015) Cardiovascular diseases in ∼30,000 patients in the Swedish Dementia Registry. J Alzheimers Dis 48, 949–958. PubMed
Cermakova P, Szummer K, Johnell K, Fastbom J, Winblad B, Eriksdotter M, Religa D (2017) Management of acute myocardial infarction in patients with dementia: Data from SveDem, the Swedish Dementia Registry. J Am Med Dir Assoc 18, 19–23. PubMed
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43, 1130–1139. PubMed
Fereshtehnejad SM, Johannsen P, Waldemar G, Eriksdotter M (2015) Dementia diagnosis, treatment, and care in specialist clinics in two Scandinavian countries: A data comparison between the Swedish Dementia Registry (SveDem) and the Danish Dementia Registry. J Alzheimers Dis 48, 229–239. PubMed
Eichler T, Hoffmann W, Hertel J, Richter S, Wucherer D, Michalowsky B, Dreier A, Thyrian JR (2016) Living alone with dementia: Prevalence, correlates and the utilization of health and nursing care services. J Alzheimers Dis 52, 619–629. PubMed PMC
Maxwell CJ, Stock K, Seitz D, Herrmann N (2014) Persistence and adherence with dementia pharmacotherapy: Relevance of patient, provider, and system factors. Can J Psychiatry 59, 624–631. PubMed PMC
Calvo-Perxas L, Lopez-Pousa S, Vilalta-Franch J, Turro-Garriga O, Blankenburg M, Febrer L, Flaque M, Vallmajo N, Aguirregomozcorta M, Genis D, Casas I, Perkal H, Coromina J, Garre-Olmo J, Registryof Dementias of Girona Study Group (2012) Central nervous system drug consumption depending on thetime between symptom onset and the diagnosis of Alzheimer’sdisease: An analysis by the Registry of Dementias of Girona. Dement Geriatr Cogn Disord 33, 104–110. PubMed
Henderson AS, Korten AE, Levings C, Jorm AF, Christensen H, Jacomb PA, Rodgers B (1998) Psychotic symptoms in the elderly: A prospective study in a population sample. Int J Geriatr Psychiatry 13, 484–492. PubMed
Xiu-Ying H, Qian C, Xiao-Dong P, Xue-Mei Z, Chang-Quan H (2012) Living arrangements and risk for late life depression: A meta-analysis of published literature. Int J Psychiatry Med 43, 19–34. PubMed
Hagg M, Houston B, Elmstahl S, Ekstrom H, Wann-Hansson C (2014) Sleep quality, use of hypnotics and sleeping habits in different age-groups among older people. Scand J Caring Sci 28, 842–851. PubMed
Enache D, Winblad B, Aarsland D (2011) Depression in dementia: Epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24, 461–472. PubMed
Urrestarazu E, Iriarte J (2016) Clinical management of sleep disturbances in Alzheimer’s disease: Current and emerging strategies. Nat Sci Sleep 8, 21–33. PubMed PMC
Douglas IJ, Smeeth L (2008) Exposure to antipsychotics and risk of stroke: Self controlled case series study. BMJ 337, a1227. PubMed PMC
Religa D, Spangberg K, Wimo A, Edlund AK, Winblad B, Eriksdotter-Jonhagen M (2012) Dementia diagnosis differs in men and women and depends on age and dementia severity: Data from SveDem, the Swedish Dementia Quality Registry. Dement Geriatr Cogn Disord 33, 90–95. PubMed
Aspberg S, Stenestrand U, Koster M, Kahan T (2013) Large differences between patients with acute myocardial infarction included in two Swedish health registers. Scand J Public Health 41, 637–643. PubMed
Hospitalizations and Mortality of Individuals with Dementia: Evidence from Czech National Registers
Socioeconomic position in childhood and cognitive aging in Europe